Interview: How to Make Life Easier for Research Sites via Technology

By

Mike Wenger, CEO & Co-founder of VersaTrial, is working to revolutionize the way clinical research sites operate, with a free, easy-to-use bookmark management system and an impressive feasibility module to save sites from lengthy questionnaires.

Mike is advocating for an industry-wide shift towards comprehensive solutions that are interoperable and unified, to make life easier for coordinators and facilitate smarter decisions for pharmaceutical companies.

Tune into this interview by Dan Sfera, the Clinical Research Guru, to learn more about how VersaTrial is revolutionizing clinical research sites.

Follow Dan Sfera, the Clinical Research Guru, on YouTube and LinkedIn and check out his podcast "Random Musings From The Clinical Trials Guru" on your favorite streaming platform. 

Picture of Mike Wenger

Mike Wenger

Mike Wenger is the founder and CEO of VersaTrial, a site enablement and engagement platform. For over 15 years, he has developed innovative solutions for the life sciences industry. Mike has lead teams at the Michael J. Fox Foundation and Epion Health and founded Clinical Trial Connect. After being acquired by TrialScope, he launched Citeline Connect, contributing to COVID-19 vaccine studies and connecting thousands of patients to research. With VersaTrial, Mike aims to improve relationships between clinical trial sites and pharma companies.

Author